Sigma® Life Science collection of Prestige Antibodies® exceeds 10,000
Publication date: 22 November 2010
Author: kdm communications limited
Tagged with: Becki Davis, Mathias Uhlén, Sigma Life Science, Sigma-Aldrich
Sigma Life Science, the innovative biological products and services business of Sigma-Aldrich® (Nasdaq:SIAL), today announced the introduction of 1,700 new products to its collection of highly characterized Prestige Antibodies.
The entire portfolio – now standing at over 10,000 antibodies and covering 8,400 protein targets – is available at www.wherebiobegins.com as part of an exclusive partnership with Atlas Antibodies AB.
As the industry’s most highly validated antibodies, each Prestige Antibody is supported by over 700 immunohistochemistry, immunofluorescence and Western blot images, with complete data for each product publicly available through the Human Protein Atlas. The continued expansion of this collection is part of the Swedish Human Proteome Resource (HPR) program to develop at least one antibody to all non-redundant human proteins by 2015. “A milestone in the Human Protein Atlas project has now been reached with the inclusion of more than 10,000 human protein-coding genes,” commented Professor Mathias Uhlén of the Royal Institute of Technology (KTH), Sweden. “With this new version of the Human Protein Atlas, we have moved towards a knowledgebased portal, with gene-centric expression profiles based on the annotation of several antibodies towards the same target.”
Becki Davis, Product Manager for Antibodies at Sigma Life Science, added: “The addition of these new Prestige Antibodies continues to expand Sigma’s antibody portfolio, providing researchers with reliable antibody products for more protein targets and more applications.” Sigma Life Science’s complete collection of over 40,000 world-class antibodies, including the Prestige Antibody portfolio, are included in the Company’s new searchable Antibody Explorer database, helping scientists to find the right product for their needs and accelerating our fundamental understanding of biology.
Advertisement:
Email newsletter
If you enjoyed this article sign-up to receive our bi-weekly email newsletter:
Latest news
- Fast plasma sample cleanup with new Phree Phospholipid Removal Plates (21 May 2012)
- Two overall winners announced at prestigious national award ceremony in London’s Science Museum (18 May 2012)
- New analysis of risk stratification for TYSABRI® published in New England Journal of Medicine (18 May 2012)
- NUCYNTA® ER (tapentadol) tablets provide pain management for patients with Diabetic Peripheral Neuropathy (DPN) (18 May 2012)
- GSK statement on tender offer to acquire Human Genome Sciences (18 May 2012)
In-depth focus:
Mass Spectrometry
This free to view Mass Spectrometry in-depth focus is sponsored by Waters, Bruker, Protea and Dr. Hochmuth and contains the following articles:
- Mass spectrometry in drug discovery - Proteomics, small molecules and metablomics
- Quantification of membrane drug transporters and application in drug discovery and development
- Anthony Bristow, AstraZeneca, poses the questions for our Mass Spectrometry Leaders Roundtable
Company directory
ABB Analytical Measurements | Almac | B&W Tek, Inc. | BASF | BD Diagnostics | Bio-Optronics, Inc. | bioMérieux | BioTek Instruments, Inc. | Bruker Optics | CAMO Software AS | Catalent Pharma Solutions | Chemspec Europe Ltd | CI Precision | Cisbio Bioassays | EMD Millipore | GE Analytical Instruments | Gerresheimer Group | HACH LANGE GMBH | HORIBA Scientific | I Holland Limited | Lonza | Merck Millipore | Pall Life Sciences | Patheon Inc | Phenomenex | Porvair Sciences Ltd | Randox Pharma Services | Rapid Micro Biosystems | Realia | Roche | rommelag® | Umetrics |
Login to access exclusive content